Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC.
Shiba-Ishii A, Isagawa T, Shiozawa T, Mato N, Nakagawa T, Takada Y, Hirai K, Hong J, Saitoh A, Takeda N, Niki T, Murakami Y, Matsubara D.
Shiba-Ishii A, et al. Among authors: murakami y.
Biochim Biophys Acta Mol Basis Dis. 2024 May 18;1870(6):167249. doi: 10.1016/j.bbadis.2024.167249. Online ahead of print.
Biochim Biophys Acta Mol Basis Dis. 2024.
PMID: 38768929